- Home
- APLS vs ADX Comparison
APLS vs ADX Comparison
Compare APLS & ADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- ADX
- Stock Information
- Founded
- APLS 2009
- ADX 1840
- Country
- APLS United States
- ADX United States
- Employees
- APLS N/A
- ADX N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- ADX Investment Managers
- Sector
- APLS Health Care
- ADX Finance
- Exchange
- APLS Nasdaq
- ADX Nasdaq
- Market Cap
- APLS 2.2B
- ADX 2.3B
- IPO Year
- APLS 2017
- ADX N/A
- Fundamental
- Price
- APLS $16.93
- ADX $20.43
- Analyst Decision
- APLS Buy
- ADX
- Analyst Count
- APLS 19
- ADX 0
- Target Price
- APLS $37.50
- ADX N/A
- AVG Volume (30 Days)
- APLS 2.9M
- ADX 182.4K
- Earning Date
- APLS 05-07-2025
- ADX 01-01-0001
- Dividend Yield
- APLS N/A
- ADX 6.68%
- EPS Growth
- APLS N/A
- ADX N/A
- EPS
- APLS N/A
- ADX N/A
- Revenue
- APLS $775,839,000.00
- ADX N/A
- Revenue This Year
- APLS $1.54
- ADX N/A
- Revenue Next Year
- APLS $22.80
- ADX N/A
- P/E Ratio
- APLS N/A
- ADX N/A
- Revenue Growth
- APLS 48.04
- ADX N/A
- 52 Week Low
- APLS $16.10
- ADX $14.94
- 52 Week High
- APLS $43.76
- ADX $19.57
- Technical
- Relative Strength Index (RSI)
- APLS 41.44
- ADX 64.27
- Support Level
- APLS $16.61
- ADX $19.91
- Resistance Level
- APLS $17.48
- ADX $19.44
- Average True Range (ATR)
- APLS 0.86
- ADX 0.24
- MACD
- APLS 0.09
- ADX 0.01
- Stochastic Oscillator
- APLS 28.47
- ADX 81.68
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About ADX Adams Diversified Equity Fund Inc.
Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally managed closed-end fund whose investment objectives are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It invests a majority of its assets in very liquid S&P 500 stocks, and has broad flexibility in the selection of stocks, but maintains a sector neutral approach. The fund has a diversified equity portfolio which consists of securities of companies from energy, consumer staples, information technology, financials, and other sectors.